< Return to Search Results

Drug Details

Drug Number:	621/10
Drug Name:	mifamurtide (Mepact)
Drug Manufacturer:	Takeda UK
BNF Category:	Malignant disease and immunosuppression
Submission type :	Full submission
Date Advice Issued:	12.07.10
Indication:	MEPACT is indicated in children, adolescents and young adults for the treatment of high-grade resectable non-metastatic osteosarcoma after macroscopically complete surgical resection.

Drug Advice

mifamurtide (Mepact)

Press Statement

Read the press statement

Read the briefing note

Minutes

Read the minutes

Notes

< Return to Search Results

Other SMC Advice for this Drug

There is currently no other SMC advice for this product

SEARCH FOR A DRUG

UNKNOWN - All BNF Categories - AnaesthesiaCardiovascular systemCentral nervous systemEar, nose and oropharynxEndocrine systemEyeGastro-intestinal systemImmunological products and vaccinesInfectionsMalignant disease and immunosuppressionMusculoskeletal and joint diseasesNutrition and bloodObstetrics, gynaecology, and urinary-tract disordersRespiratory systemSkin

UNKNOWN - All Types of Submission - Abbreviated SubmissionFull submissionIRPNon submissionResubmission

Help on how to improve your search.